Summary
The AI statements are largely not supported by the provided FDA-approved prescribing information excerpts for magnesium sulfate in 5% dextrose injection, USP, and include multiple hangover/magnesium deficiency/day-to-day intake claims that are absent from the label. Several statements could mislead about uses and mechanisms not addressed in the supplied labeling.
Category Scores
Accurate Statements
Unsupported Statements
Alcohol can reduce magnesium levels in the body.
Not supported by the provided label excerpts; only alcohol appears in the list of drugs/classes associated with magnesium renal losses.
Acute ethanol ingestion decreases magnesium levels in the blood.
Not supported by the provided label excerpts.
Alcohol can increase the excretion of magnesium in the urine.
Not explicitly stated as a general effect of alcohol in the provided label excerpts; the label only lists alcohol under drug-induced renal losses of magnesium.
Increased urinary magnesium excretion can lead to dehydration due to loss of both magnesium and water.
Not supported by the provided label excerpts.
Magnesium supplements may help alleviate symptoms associated with magnesium deficiency such as muscle cramps, weakness, and fatigue.
Not supported by the provided label excerpts.
Magnesium supplements can be effective in alleviating symptoms of hangover.
Not supported by the provided label excerpts.
The efficacy of magnesium supplements for hangover varies across studies.
Not supported by the provided label excerpts.
The recommended daily intake of magnesium for adults is 400-420 mg.
Not supported by the provided label excerpts.
High doses of magnesium (>350 mg/day) may cause gastrointestinal side effects such as diarrhea or stomach cramps.
Not supported by the provided label excerpts. The provided adverse reaction excerpt describes effects of magnesium intoxication (e.g., hypotension, depressed reflexes, respiratory paralysis) and hypocalcemia; it does not mention GI effects at the cited thresholds.
Gastrointestinal side effects from high-dose magnesium may be exacerbated by alcohol consumption.
Not supported by the provided label excerpts.
Contradictions
Low
AI Statement
Magnesium supplements can be effective in alleviating symptoms of hangover.
Label Reference
Section 1 (indications and usage) supports prevention/control of seizures in pre-eclampsia and eclampsia; no support for hangover treatment is provided in the supplied excerpts.
Low
AI Statement
The recommended daily intake of magnesium for adults is 400-420 mg.
Label Reference
No dietary-recommended intake information is present in the supplied label excerpts; the claim does not align with the provided labeling scope.
Important Omissions
The provided label indicates magnesium sulfate in 5% dextrose injection, USP is intended for intravenous use only and is indicated for prevention/control of seizures in pre-eclampsia/eclampsia; none of the AI statements address the approved indication/route and instead discuss hangover and supplements.
Importance:
High
Key label safety information such as fetal harm with continuous administration beyond 5 to 7 days and magnesium intoxication risk in renal insufficiency (with monitoring) is not addressed in the AI statements.
Importance:
High
Safety Assessment
Potential Patient Risk:
High
The statements promote off-label, non-indicated uses (hangover treatment) and provide unsupported dosing/side-effect guidance not reflected in the supplied label excerpts, potentially leading to inappropriate use and misunderstanding of the product’s approved indication and key safety warnings.
Regulatory Assessment
| On Label |
No |
| Off-label Discussion |
Yes |
| Promotes Unapproved Use |
Yes |
| Hallucination Risk |
High |
Recommendation
Not Aligned
Primary Issue
Multiple unsupported claims about hangover treatment, magnesium supplements, daily intake, and GI side effects are absent from the provided FDA-approved labeling excerpts; approved indication and IV-only administration are omitted.
Suggested Improvement
Limit statements to what is present in the provided label excerpts (approved indication for pre-eclampsia/eclampsia seizure prevention/control; IV-only administration; contraindication timing; fetal harm with prolonged administration; renal insufficiency/intoxication and monitoring; drug-induced renal losses listing includes alcohol). Avoid hangover/supplement efficacy, adult RDA values, and GI side-effect thresholds unless supported by the supplied label text.